Meanwhile, Retail Pharmacy International - the subsidiary within Walgreen Boots Alliance of which Boots in the United Kingdom is a part - recorded sales of $3.1 billion (£2.2 billion), a 0.8 per cent decrease on a constant currency basis. Finally, Northern Capital Management LLC grew its stake in Walgreens Boots Alliance by 0.4% in the second quarter. Arrowstreet Capital Limited Partnership increased its holdings in Walgreens Boots Alliance by 471.4% in the 2nd quarter. Retail sales fell 2.8% in the first quarter compared with the year-ago period due to declines in consumables and general merchandise sales. Also, it has an estimated price-earnings (P/E) multiple of 23.18 and a trailing 12-month price-earnings (P/E) multiple of 43.84.
INVESCO LTD. lowered its stake in Walgreens Boots Alliance, Inc. The stock of Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) earned "Neutral" rating by Piper Jaffray on Tuesday, January 3. Based on that Walgreens Boots Alliance's stock can be considered overvalued, based on its fundamentals. Year-to-date, WBA has gained 3.98%, versus a 1.35% rise in the benchmark S&P 500 index during the same period. The fund owned 289,487 shares of the pharmacy operator's stock after selling 453,469 shares during the quarter.
WBA is trading at price-to-earnings (PE) ratio of 19.88x, which suggests that Walgreens Boots Alliance is undervalued based on its latest annual earnings update compared to the consumer retailing average of 20.12x, and overvalued compared to the U.S. market average ratio of 19.68x. The stock price of MXIM is moving up from its 20 days moving average with 3.71% and isolated positively from 50 days moving average with 2.94%. (NASDAQ:WBA) also have important role in eyes of active investors, firm has price to earnings growth of 1.53, which is a valuation metric for determining relative trade-off among price of a stock. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00. The average 1-year price target for (WBA) reveals an average price target of $85.61 per share. The pharmacy operator reported $1.31 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. On a Monthly basis the stock is 5.68%. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.
Walgreens Boots Alliance announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. Cibc World Markets Corp now owns 374,075 shares of the pharmacy operator's stock valued at $31,067,000 after acquiring an additional 30,341 shares in the last quarter. A low price-to-sales ratio, typically less than 1.0, is considered a good value.
Like-for-likes also decreased by 4.1 per cent. Stockholders of record on Monday, November 13th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date was Friday, November 10th. Walgreens Boots Alliance's payout ratio is 42.33%.
In other news, COO Ornella Barra purchased 124,000 shares of the business's stock in a transaction that occurred on Tuesday, February 7th.
On 2/7/2017 Ornella Barra, COO, bought 124,000 with an average share price of $80.93 per share and the total transaction amounting to $10,035,320.00. Following the completion of the acquisition, the director now directly owns 600 shares in the company, valued at approximately $48,408. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. The disclosure for this sale can be found here. "Throughout 2017, we continued to demonstrate how we as a company embed our CSR values in everything we do", stated Ornella Barra, Walgreens Boots Alliance co-COO and chairman of the Corporate Social Responsibility Committee. Finally, Raymond James Financial restated a "market perform" rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. On Wednesday, July 12 the stock rating was downgraded by Canaccord Genuity to "Hold".